Business Context and Reporting Period
This Form 8-K Current Report was filed by SeaStar Medical Holding Corporation on June 25, 2026. The report discloses the approval and execution of a retention bonus program for key executives, effective as of the report date, with agreements formally entered into on June 29, 2026.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to specific executive compensation obligations:
- Eric Schlorff (CEO): Total retention bonus of $200,000 plus restricted stock valued at approximately $16,666.50 per installment.
- Kevin Chung: Total retention bonus of $140,000 plus restricted stock valued at approximately $11,666.50 per installment.
Material Changes
The primary material change reported is the implementation of a new 2026 Retention Bonus Program for long-serving employees, specifically targeting two executives. This represents a new contractual obligation for the company to pay cash and issue equity over the next nine months, contingent on continued employment.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking guidance, revenue outlook, or general management commentary regarding business strategy. The focus is strictly on the terms of the retention agreements:
- Vesting Schedule: Bonuses are paid in three equal installments on July 1, 2026; November 1, 2026; and March 1, 2027.
- Equity Component: Executives receive an additional 25% of each cash payment in common stock shares, valued at the closing price on the vesting date.
- Termination Conditions: Payments cease if an executive departs prior to a vesting date. In the event of separation without cause, a pro-rata amount for the upcoming payment is due.
Investor Verification Checklist
- Verify the exact share count to be issued for the equity component once the vesting dates occur, as this depends on the stock price on July 1, November 1, and March 1.
- Review the full text of Exhibit 10.1 and Exhibit 10.2 for any additional covenants or clawback provisions not summarized in the 8-K.
- Confirm the total cash outflow impact on the company's liquidity for the remainder of 2026 and early 2027.
- Check subsequent filings to ensure the executives remain employed through the required vesting dates to trigger the payments.